Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 1/24/2026

Arthrocentesis with Intra‑articular Steroid Injection – Evidence‑Based Recommendations

1. Pre‑Procedure Requirements

  • Obtain and document informed consent that outlines expected benefits (pain relief, reduced inflammation) and quantified risks: infection 0.035%, transient hyperglycaemia in diabetics, and vasovagal reactions 2.6% [Rheumatology Society guideline] 1
  • Screen for diabetes and advise patients with suboptimal control to monitor blood glucose for days 1–3 after injection because of a transient rise in glycaemia [Rheumatology Society guideline] 2
  • Confirm the diagnosis and exclude septic arthritis before any steroid administration [Rheumatology Society guideline] 3
  • Do not withhold the procedure in patients on antithrombotic therapy or with clotting disorders unless the individual bleeding risk is deemed high [Rheumatology Society guideline] 2
  • Prepare the procedural environment: a clean, quiet, private, well‑lit room; patient positioned on an adjustable couch/examination table that can lie flat; all aseptic supplies and resuscitation equipment (for 2.6% vasovagal reaction risk) readily available [Rheumatology Society guideline] 1
  • Consider having a second healthcare professional present to assist with safety and documentation [Rheumatology Society guideline] 1

2. Aseptic Technique

  • Strict aseptic technique is mandatory; the current incidence of iatrogenic septic arthritis is 0.035% (≈3 per 7 900 procedures) [Rheumatology Society guideline] 1
  • Wear sterile surgical gloves, prepare the skin with alcohol, iodine, or chlorhexidine, and change needles between medication preparation and joint injection [Rheumatology Society guideline] 1

3. Local Anaesthesia

  • Offer local anaesthetic to all patients to reduce procedural discomfort and prolong pain relief [Rheumatology Society guideline] 1
  • Available options:
    • Topical (ethyl‑chloride spray or EMLA® cream)
    • Infiltrative (injection along the needle tract or subcutaneously)
    • Intra‑articular (mixed with the glucocorticoid or administered separately) [Rheumatology Society guideline] 1

4. Needle Placement & Accuracy

  • Use ultrasound guidance when available to improve needle placement accuracy, especially for deep joints such as the hip and shoulder [Rheumatology Society guideline] 2
  • Ultrasound‑guided injections increase delivery accuracy, although overall clinical outcomes are comparable to landmark‑guided techniques [Rheumatology Society guideline] 4
  • For landmark‑guided knee injections, the superolateral approach yields 91 % accuracy (95 % CI 84‑99 %) [Rheumatology Society guideline] 1
  • Select the optimal entry route for each peripheral joint based on its specific anatomy [Rheumatology Society guideline] 1
  • Ensure the operator has appropriate training and experience, as expertise markedly influences success rates [Rheumatology Society guideline] 1

5. Aspiration & Steroid Injection

  • Aspirate synovial fluid when present to verify intra‑articular needle position [Rheumatology Society guideline] 1
  • After confirming placement, inject a long‑acting insoluble glucocorticoid; dosing and technique should be tailored to the specific joint and clinical indication [Rheumatology Society guideline] 5

6. Post‑Procedure Care

  • Advise patients to avoid over‑use of the injected joint for 24 hours after the procedure [Rheumatology Society guideline] 2
  • Discourage strict immobilisation; gentle range‑of‑motion activities are recommended [Rheumatology Society guideline] 2
  • For diabetic individuals, reinforce glucose monitoring during days 1‑3 post‑injection [Rheumatology Society guideline] 2
  • Timing relative to joint replacement: perform the injection ≥ 3 months before a planned arthroplasty; after replacement, obtain surgical team approval before any further injections [Rheumatology Society guideline] 2
  • Re‑injection decisions should be based on documented benefit from prior injections, patient‑specific factors (e.g., systemic therapy, comorbidities), and the specific steroid preparation used [Rheumatology Society guideline] 2

7. Safety & Common Pitfalls

  • Never inject steroids without a confirmed appropriate diagnosis and exclusion of septic arthritis [Rheumatology Society guideline] 3
  • Skipping informed consent is unacceptable; patient surveys highlight its critical importance [Rheumatology Society guideline] 1
  • Always keep resuscitation equipment at hand because vasovagal reactions occur in 2.6 % of cases [Rheumatology Society guideline] 1
  • Remember to counsel diabetic patients about the need for post‑injection glucose monitoring [Rheumatology Society guideline] 2
  • Avoid recommending strict immobilisation after the procedure, as it is not supported by evidence [Rheumatology Society guideline] 2

Immediate Evaluation and Management of Suspected Septic Arthritis after Intra‑articular Steroid Injection

Pre‑injection Precautions

  • Steroids must never be administered intra‑articularly without first ruling out septic arthritis; this precaution applies to all post‑injection complications. 6

Diagnostic Recommendations

  • Superficial vein thrombosis has been reported as a complication of intra‑articular steroid injection; it presents with warmth, redness, and pain along superficial veins and should be investigated with duplex ultrasound when suspected. 6

Infection‑Control Practices

  • Aseptic technique is mandatory for every intra‑articular procedure, yet septic arthritis can still occur despite strict asepsis. 6

Post‑procedure Activity Guidance

  • Rheumatology guidelines advise patients to avoid over‑using the injected joint for at least 24 hours after an uncomplicated injection. 6

Timing and Referral Recommendations

  • If the patient cannot reach the injecting physician within a few hours, they should present to an emergency department for urgent assessment. 6
  • When symptoms are mild but concerning, the patient should contact the injecting physician’s office promptly and be evaluated within hours. 6
  • The physician’s office should have the capability to perform joint aspiration when septic arthritis is suspected. 6

REFERENCES

1

eular recommendations for intra-articular therapies. [LINK]

Annals of the Rheumatic Diseases, 2021

2

eular recommendations for intra-articular therapies. [LINK]

Annals of the Rheumatic Diseases, 2021

3

eular recommendations for intra-articular therapies. [LINK]

Annals of the Rheumatic Diseases, 2021

4

eular recommendations for intra-articular therapies. [LINK]

Annals of the Rheumatic Diseases, 2021

5

eular recommendations for intra-articular therapies. [LINK]

Annals of the Rheumatic Diseases, 2021

6

eular recommendations for intra-articular therapies. [LINK]

Annals of the Rheumatic Diseases, 2021